ExecutiveOrdersEO
EO 14081Executive OrderBiden · D Quiet signal

Executive Order 14081

Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy

This executive order launches a whole-of-government initiative to advance U.S. biotechnology and biomanufacturing capabilities across health, climate, energy, agriculture, and national security sectors. It mandates numerous agency reports and plans with specific deadlines, establishes a Data for the Bioeconomy Initiative, creates workforce development programs with equity commitments, streamlines biotechnology regulation, strengthens biosafety and biosecurity protections, and tasks intelligence agencies with assessing foreign threats to the U.S. bioeconomy.

Federal Register Open PDF 87 FR 56849

Impact dates

  1. Biomass supply chain resilience plan from Agriculture

  2. Biobased procurement program establishment for agencies without them

  3. Unified biotechnology regulation website updates

  4. First annual regulatory progress update

  5. ITWG NAICS/NAPCS revision recommendations

  6. Regulatory reform plan from USDA, EPA, FDA

  7. Implementation plan for R&D recommendations (100 days after reports received)

  8. Data for the Bioeconomy Initiative report from OSTP

  9. DNI classified assessments on foreign bioeconomy threats

  10. Workforce development plan from Commerce, Labor, Education, APDP, OSTP, NSF

  11. Sector-specific R&D reports from HHS, Energy, Agriculture, Commerce, NSF

  12. Domestic biomanufacturing strategy from APNSA and APEP

  13. DHS vulnerability assessments of bioeconomy critical infrastructure

  14. Biosafety and biosecurity plan from HHS and DHS

  15. First biobased procurement spending reports from procuring agencies

  16. State Department international engagement plan

  17. PCAST report on bioeconomy competitiveness

  18. ITWG establishment for NAICS/NAPCS revisions

  19. OMB budget crosscut on biotechnology and biomanufacturing spending

  20. NIST create and publish bioeconomy lexicon

Key directives

  • Establish Data for the Bioeconomy Initiative with report due within 240 days
  • Submit 5 sector-specific R&D reports within 180 days (HHS, Energy, Agriculture, Commerce, NSF)
  • Develop implementation plan within 100 days of receiving R&D reports
  • Perform OMB budget crosscut within 90 days
  • Develop domestic biomanufacturing strategy within 180 days
  • Establish biobased procurement programs within 1 year for agencies without them
  • Complete biobased procurement training within 2 years
  • Produce workforce development plan within 200 days
  • Develop regulatory reform plan within 280 days; update unified website within 1 year
  • Launch Biosafety and Biosecurity Innovation Initiative
  • DNI provide classified threat assessments within 240 days
  • Develop threat mitigation plan within 120 days of DNI assessments

Who is ordered

Timeline

Immediate

  • OMB budget crosscut due (90 days)
  • NIST bioeconomy lexicon due (90 days)
  • ITWG establishment (120 days)

Near term (90d)

  • Sector-specific R&D reports due from HHS, Energy, Agriculture, Commerce, NSF (180 days)
  • Data for the Bioeconomy Initiative report (240 days)
  • Domestic biomanufacturing strategy (180 days)
  • DNI threat assessments (240 days)
  • Regulatory reform plan (280 days)
  • Biosafety and biosecurity plan (180 days)
  • Biobased procurement reporting begins (180 days, then annual)
  • Workforce development plan (200 days)
  • State Department international engagement plan (180 days)

Long term

  • Implementation plan for R&D recommendations (100 days after reports received)
  • Biomass supply chain resilience plan (1 year)
  • Biobased procurement training completion (2 years)
  • Unified biotechnology regulation website updates (1 year)
  • Annual regulatory progress updates for 3 years
  • Agency implementation reports on biotechnology investments (2 years)
  • Workforce development program reports (2 years)
  • NAICS/NAPCS revision recommendations (1 year, with 2026 review)
  • Federal procurement security review recommendations (1 year)
  • Biobased procurement increase target by 2025

Risks & tensions

  • Implementation depends heavily on appropriations and agency capacity; EO explicitly notes 'subject to availability of appropriations'
  • Classified threat assessments (Sec. 11) create tension with transparency goals elsewhere in the EO
  • Data sharing objectives (Sec. 4, Sec. 12) conflict with cybersecurity and foreign adversary protection mandates
  • Equity commitments (Sec. 1, Sec. 7) lack specific enforcement mechanisms or funding guarantees
  • Regulatory streamlining (Sec. 8) may reduce oversight capacity if not carefully balanced with biosafety goals
  • Vague 'as appropriate and consistent with applicable law' qualifiers throughout create implementation uncertainty
  • Foreign adversary definitions and procurement restrictions could affect international research collaboration
  • Compressed timeline for implementation plan (100 days after reports) may limit thorough interagency coordination
Executive Order 14081: Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy · Executive Orders